“…UGT1A6 is widely expressed in human tissues at variable levels, including the liver, kidney, GI tract (stomach, small intestine, colon), trachea, brain, adrenal, bladder, ovary, and lung (55,134,354,513,544,618). The UGT1A6 proximal promoter contains three TATA boxes that function in a cell type-specific manner (501,599): all three TATA boxes are active in human liver; however, differen- UGT1A7 is expressed in the aerodigestive tract (e.g., oral cavity, pharyngeal and laryngeal mucosa, esophagus, stomach, small intestine, colon) as well as cervix, trachea, kidney, and bladder (134,513,544,796,798); however, it is absent from the liver. The UGT1A7 proximal promoter has a functionally polymorphic TATA box with the rarer variant (MAF 0.29) showing~30% of the promoter activity of the common variant (386).…”